3,48,421 fresh Covid cases and 4,205 Covid deaths in last 24 hours

Mangalore Today News Network / NDTV

New Delhi, May 12, 2021:      India saw a record rise in COVID-19 deaths with 4,205 fresh fatalities taking the country’s death count to 2,54,197, while 3,48,421 new coronavirus infections were reported, according to the Union Health Ministry data updated on Wednesday.

 

The total tally of COVID-19 cases in the country now stands at 2,33,40,938. The active cases have reduced to 37,04,099 comprising 15.87 per cent of the total infections, while the national COVID-19 recovery rate has improved to 83.04 per cent, the data updated at 8 am showed.

The number of people who have recuperated from the disease surged to 1,93,82,642 while the case fatality rate was recorded at 1.09 per cent, the data stated.

India’s COVID-19 tally had crossed the 20-lakh mark on August 7, 30 lakh on August 23, 40 lakh on September 5 and 50 lakh on September 16.It went past 60 lakh on September 28, 70 lakh on October 11, crossed 80 lakh on October 29, 90 lakh on November 20 and surpassed the one-crore mark on December 19. India crossed the grim milestone of 2 crore on May 4.

Meanwhile, Bharat Biotech’s COVID-19 vaccine Covaxin was on Tuesday recommended by an expert panel for phase-2 and phase-3 clinical trials on those aged between two to 18 years, official sources said.

The trial will take place in 525 subjects at various sites, including AIIMS, Delhi, AIIMS, Patna and Meditrina Institute of Medical Sciences, Nagpur.

The Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organization (CDSCO) on Tuesday deliberated upon Hyderabad-based Bharat Biotech’s application, seeking permission to conduct phase II/III clinical trials to evaluate the safety, reactogenicity and immunogenicity of Covaxin jabs in children aged 2 to 18 years.